Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment in phase 3 and 3b clinical trials

Bimekizumab infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from 2 years of treatment in phase 3 and 3b clinical trials

Saved in:
Bibliographic Details
Published in:Skin (Milwood, N.Y.) Vol. 6; no. 6; p. s72
Main Authors: Armstrong, A, Langley, RG, Gordon, KB, Warren, RB, Thaçi, D, Stein Gold, L, Peterson, L, Madden, C, Nunez Gomez, N, De Cuyper, D, Costanzo, A
Format: Journal Article
Language:English
Published: 16-11-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2574-1624
2574-1624
DOI:10.25251/skin.6.supp.72